Lytix Biopharma AS Balance Sheet

Financials in millions NOK. Fiscal year is January - December.

Millions NOK. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	29.08	130.79	27.37	94.55	197.28	28.45
Short-Term Investments	60.92	-	23.18	50.61	-	-
Cash & Short-Term Investments	90.01	130.79	50.55	145.16	197.28	28.45
Cash Growth	106.77%	158.75%	-65.18%	-26.42%	593.43%	122.33%
Accounts Receivable	-	0.46	-	-	-	-
Other Receivables	3.12	12.1	12.12	6	5.13	3.63
Receivables	3.12	12.56	12.12	6	5.13	3.63
Prepaid Expenses	-	0.55	0.66	0.74	0.55	0.54
Other Current Assets	-	-	0	-	-	-0
Total Current Assets	93.13	143.9	63.33	151.89	202.96	32.62
Property, Plant & Equipment	2.33	2.63	0.55	1.38	2.14	-
Other Long-Term Assets	-	-	-	0	-	-
Total Assets	95.46	146.54	63.87	153.27	205.1	32.62
Accounts Payable	4.99	5.02	3.57	7	1.48	3.28
Accrued Expenses	-	24.44	2.38	2.11	3.77	4.63
Current Portion of Leases	0.96	0.76	0.45	0.87	0.83	-
Current Income Taxes Payable	-	1.19	1.36	0.95	2.03	2.85
Other Current Liabilities	9.61	5.36	4.74	6.83	6.06	1.97
Total Current Liabilities	15.55	36.76	12.51	17.76	14.17	12.73
Long-Term Leases	1.47	1.88	0.04	0.48	1.34	-
Other Long-Term Liabilities	-	-0	-	-	-	-
Total Liabilities	17.02	38.64	12.56	18.24	15.51	12.73
Common Stock	6.83	6.82	4.01	4.01	3.87	2.62
Additional Paid-In Capital	71.61	101.08	47.31	131.03	185.72	17.27
Comprehensive Income & Other	-	-	-	-	-0	-
Shareholders' Equity	78.44	107.89	51.32	135.03	189.59	19.89
Total Liabilities & Equity	95.46	146.54	63.87	153.27	205.1	32.62
Total Debt	2.43	2.64	0.49	1.34	2.17	-
Net Cash (Debt)	87.57	128.15	50.06	143.81	195.11	28.45
Net Cash Growth	115.12%	156.01%	-65.19%	-26.29%	585.80%	122.33%
Net Cash Per Share	1.28	2.37	1.25	3.63	5.88	1.08
Filing Date Shares Outstanding	68.26	68.26	40.07	40.07	40.07	26.23
Total Common Shares Outstanding	68.26	68.16	40.07	40.07	38.74	26.23
Working Capital	77.58	107.14	50.81	134.13	188.8	19.89
Book Value Per Share	1.15	1.58	1.28	3.37	4.89	0.76
Tangible Book Value	78.44	107.89	51.32	135.03	189.59	19.89
Tangible Book Value Per Share	1.15	1.58	1.28	3.37	4.89	0.76
Machinery	-	0.2	0.2	0.15	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.